Canadian radioisotope firm Nordion said it has received approval to be acquired by sterilization services vendor Sterigenics under the Investment Canada Act.
The action is the last regulatory hurdle required for the buyout. Earlier this month, the U.S. Federal Trade Commission approved the deal by declining to challenge it.
The transaction is expected to close on August 6, after which holders of Nordion common shares will receive $13 in cash per share, Nordion said.
